dr. messersmith on the need for biomarkers to distinguish between vegf inhibitors in crc
Published 5 years ago • 57 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:46
dr. messersmith on molecular markers to be aware of in crc
-
1:23
dr. messersmith on the rise of molecular testing in mcrc
-
2:08
dr. messersmith on choosing a treatment option in mcrc
-
6:26
role of the vegf inhibitor aflibercept in metastatic colorectal cancer
-
1:56
key investigations in advanced colorectal cancer
-
6:32
finding actionable biomarkers in colorectal cancer
-
13:46
choosing between anti-vegf and anti-egfr targeted therapy
-
1:20
dr. eng on unmet needs in early-onset crc
-
34:17
colorectal cancer breakout: biomarkers for effective treatment
-
1:03:16
targeted therapies and biomarkers in advanced colorectal cancer - m. s. lee - 20180725
-
1:23
dr. black on biomarkers for immunotherapy in bladder cancer
-
26:20
colorectal cancer: the link between the immune microenvironment and outcomes
-
1:24
dr. eng on addressing unmet needs for colorectal cancer
-
6:17
healthy lifestyle and improved survival benefit in crc
-
3:02
final thoughts on the treatment of metastatic colorectal cancer
-
1:39
biomarkers and biomarker testing - an overview for colorectal cancer patients
-
1:22
dr. rule on searching for a biomarker indicating indolent mcl
-
3:39
anti-vegf/immunotherapy combinations in kidney cancer
-
10:06
understanding tumor sidedness in colorectal cancer